Regionally limited or rare infections: prevention after hematopoietic cell transplantation

Bone Marrow Transplant. 2009 Oct;44(8):489-94. doi: 10.1038/bmt.2009.260.

Authors

J Gea-Banacloche¹, H Masur, C Arns da Cunha, T Chiller, L V Kirchhoff, P Shaw, M Tomblyn, C Cordonnier; Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Disease Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Diseases Canada; Centers for Disease Control and Prevention

Affiliation

¹ Experimental Transplantation and Immunology, National Cancer Institute, NIH, Bethesda, MD 20892-1203, USA. banacloj@mail.nih.gov

PMID: 19861983
DOI: 10.1038/bmt.2009.260

No abstract available

Publication types

Practice Guideline

MeSH terms

Antibiotic Prophylaxis
Hematopoietic Stem Cell Transplantation*
Humans
Opportunistic Infections / prevention & control*